[Federal Register Volume 62, Number 18 (Tuesday, January 28, 1997)]
[Notices]
[Page 4053]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-1996]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Advisory Committee on Immunization Practices; Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meeting.
Name: Advisory Committee on Immunization Practices (ACIP).
Times and Dates: 8:15 a.m.-6:15 p.m., February 12, 1997; 8:30
a.m.-2:45 p.m., February 13, 1997.
Place: CDC, Auditorium B, Building 2, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The Committee is charged with advising the Director,
CDC, on the appropriate uses of immunizing agents. In addition,
under 42 U.S.C. Sec. 1396s, the Committee is mandated to establish
and periodically review and, as appropriate, revise, the list of
vaccines for administration to vaccine-eligible children through the
Vaccines for Children (VFC) Program, along with schedules regarding
the appropriate periodicity, dosage, and contraindications
applicable to the vaccines.
Matters to be Discussed: Under the authority of 42 U.S.C.
Sec. 1396s, the Committee will consider adoption of VFC resolutions
(1) To provide for initial inclusion in the VFC Program of new
vaccines that combine previously VFC-designated vaccines, (2) to
approve use in the VFC Program of FDA licensed vaccines that combine
Haemophilus influenzae type b (Hib) and Hepatitis B vaccines, and
(3) to approve use in the VFC Program of FDA licensed vaccines that
combine Diphtheria-Tetanus-Acellular Pertussis (DTaP) and
Haemophilus influenzae type b (Hib) vaccines or are licensed by the
FDA for combined administration.
Other topics to be discussed include: Updates on the National
Vaccine Program; updates on the Vaccine Injury Compensation Program;
updates on the combination vaccines workgroup; recommended uses for
licensed combination vaccines and a vote to cover combination
vaccines in the Vaccines for Children Program; vaccination of HIV-
infected persons; measles, mumps, and rubella recommendations;
serogroup C meningococcal conjugate vaccine: update on cost-
effectiveness of routine use in the U.S.; status of recently
licensed acellular pertussis vaccines; approval of draft statement
on programmatic strategies to increase immunization coverage--
reminder/recall; update on U.S. influenza; worldwide virologic
surveillance and vaccine strain selection for the 1997 influenza
season; update on Parke Davis influenza vaccine recall; impact of
influenza in pregnant women; investigation of a possible association
between Guillain-Barre syndrome and the 1992-1993 and 1993-1994
influenza vaccinations; proposed modifications in the ACIP influenza
statement for 1997; recommendations on the use of
Rotashield (Rotavirus vaccine) as part of the routine
childhood immunization schedule; rabies vaccine: vaccination of
ferrets; a comparison of the safety of combined adult preparation
diphtheria and tetanus toxoids versus single antigen tetanus toxoid
in adults; meeting the challenge of new vaccines with the vaccine
economics initiative; and progress in developing new jet injectors
for immunization. Other matters of relevance among the Committee's
objectives may be discussed.
Agenda items are subject to change as priorities dictate.
Contact Person For More Information: Gloria A. Kovach, Committee
Management Specialist, CDC, 1600 Clifton Road, NE., M/S D50,
Atlanta, Georgia 30333, telephone 404/639-7250.
Dated: January 22, 1997.
Carolyn J. Russell,
Director, Management Analysis and Services Office Centers for Disease
Control and Prevention (CDC).
[FR Doc. 97-1996 Filed 1-27-97; 8:45 am]
BILLING CODE 4163-18-P
